Rita Humeniuk

7PUBLICATIONS
34CO-AUTHORS
Infectious diseasesPharmacogenomicsInformation systems development methodologies and practiceMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2025
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.

Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang

|Feb 13, 2025
Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment.

Sean Regan, Rita Humeniuk, Luzelena Caro

|Jan 31, 2025
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent.

Chi-Chi Peng, Rita Humeniuk, Anuja Raut

|Jun 28, 2024
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.

Olena Anoshchenko, Mazin Abdelghany, Amos Lichtman

|Mar 27, 2024
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.

Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk

|Sep 09, 2023
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.

Rita Humeniuk, Kavita Juneja, Shuguang Chen

Pageof 2